177.62
Schlusskurs vom Vortag:
$184.14
Offen:
$177.38
24-Stunden-Volumen:
782.92K
Relative Volume:
0.53
Marktkapitalisierung:
$9.25B
Einnahmen:
$45.08B
Nettoeinkommen (Verlust:
$188.00M
KGV:
52.39
EPS:
3.3907
Netto-Cashflow:
$251.00M
1W Leistung:
-3.77%
1M Leistung:
+0.84%
6M Leistung:
+19.61%
1J Leistung:
-41.87%
Molina Healthcare Inc Stock (MOH) Company Profile
Firmenname
Molina Healthcare Inc
Sektor
Branche
Telefon
(562) 435-3666
Adresse
200 OCEANGATE, SUITE 100, LONG BEACH, CA
Compare MOH vs UNH, CVS, ELV, CI, HUM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
MOH
Molina Healthcare Inc
|
177.46 | 9.59B | 45.08B | 188.00M | 251.00M | 3.3907 |
|
UNH
Unitedhealth Group Inc
|
379.11 | 352.79B | 449.71B | 12.81B | 19.67B | 13.24 |
|
CVS
Cvs Health Corp
|
91.14 | 118.99B | 407.94B | 2.90B | 7.39B | 2.2771 |
|
ELV
Elevance Health Inc
|
388.47 | 85.71B | 200.42B | 5.24B | 6.45B | 23.50 |
|
CI
Cigna Group
|
281.63 | 75.72B | 278.13B | 6.74B | 7.66B | 23.60 |
|
HUM
Humana Inc
|
303.67 | 36.97B | 137.20B | 1.15B | 1.27B | 9.3439 |
Molina Healthcare Inc Stock (MOH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-20 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-10-24 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2025-10-16 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-10-14 | Eingeleitet | Goldman | Neutral |
| 2025-07-25 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2025-07-25 | Herabstufung | Truist | Buy → Hold |
| 2025-07-10 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-06-09 | Eingeleitet | Morgan Stanley | Overweight |
| 2025-04-22 | Eingeleitet | Bernstein | Outperform |
| 2025-04-15 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-03-05 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-12-17 | Fortgesetzt | JP Morgan | Neutral |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-03-28 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2024-02-15 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2023-06-20 | Eingeleitet | UBS | Neutral |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-12-13 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-10-03 | Fortgesetzt | JP Morgan | Overweight |
| 2022-06-17 | Eingeleitet | Loop Capital | Hold |
| 2022-05-26 | Herabstufung | BofA Securities | Buy → Underperform |
| 2021-12-14 | Eingeleitet | Goldman | Buy |
| 2021-11-22 | Fortgesetzt | Deutsche Bank | Hold |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Neutral |
| 2021-05-19 | Eingeleitet | Wells Fargo | Underweight |
| 2021-03-30 | Eingeleitet | Credit Suisse | Outperform |
| 2021-03-10 | Eingeleitet | Mizuho | Buy |
| 2021-02-19 | Fortgesetzt | Barclays | Overweight |
| 2021-01-21 | Eingeleitet | Goldman | Neutral |
| 2020-09-22 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2020-07-01 | Fortgesetzt | SVB Leerink | Outperform |
| 2020-06-16 | Hochstufung | Cowen | Market Perform → Outperform |
| 2020-04-14 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2020-04-08 | Hochstufung | BofA/Merrill | Underperform → Buy |
| 2019-10-30 | Herabstufung | Jefferies | Buy → Hold |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Buy |
| 2019-07-31 | Bestätigt | BofA/Merrill | Underperform |
| 2019-06-03 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2019-05-31 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2019-04-30 | Bestätigt | BofA/Merrill | Underperform |
| 2019-01-14 | Eingeleitet | Stephens | Equal-Weight |
| 2019-01-08 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-11-13 | Hochstufung | Jefferies | Hold → Buy |
| 2018-10-12 | Herabstufung | Jefferies | Buy → Hold |
| 2018-10-10 | Eingeleitet | Evercore ISI | In-line |
| 2018-06-27 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2018-06-22 | Hochstufung | Jefferies | Hold → Buy |
| 2018-03-28 | Bestätigt | Leerink Partners | Outperform |
| 2018-01-16 | Hochstufung | JP Morgan | Neutral → Overweight |
Alle ansehen
Molina Healthcare Inc Aktie (MOH) Neueste Nachrichten
Why Molina Healthcare Is Dropping 5.6%: UBS Maintains Neutral - AlphaStreet
Important Notice to Long-Term Shareholders of Molina - GlobeNewswire
Here's what to expect from Molina Healthcare's next earnings report - MSN
Molina Healthcare, Inc. (MOH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Molina (MOH) up 3.8% since last earnings report: Can it continue? - MSN
W.G. Shaheen & Associates DBA Whitney & Co's Molina Healthcare Inc(MOH) Holding History - GuruFocus
WASHINGTON CAPITAL MANAGEMENT, INC's Molina Healthcare Inc(MOH) Holding History - GuruFocus
Molina Healthcare Inc. stock outperforms competitors on strong trading day - MarketWatch
Here's Why Molina (MOH) Could be Great Choice for a Bottom Fisher - Yahoo Finance
UBS Adjusts Price Target on Molina Healthcare to $202 From $180, Maintains Neutral Rating - Moomoo
MOH News | MOLINA HEALTHCARE INC (NYSE:MOH) - ChartMill
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Molina Healthcare, Inc. (MOH) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Molina Healthcare Inc stock (US6093511094): earnings beat keeps Medicaid specialist in focus - AD HOC NEWS
Molina Healthcare Inc. stock outperforms competitors despite losses on the day - MarketWatch
Molina Healthcare’s SWOT analysis: stock faces margin pressures - Investing.com
Molina Healthcare Stock Sinks to 52-Week Low Amid Earnings Revision and Sector Pressures - MSN
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Molina Healthcare, Inc. (MOH) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Molina Healthcare Inc (MOH) Stock Analysis: Navigating Challenges in the Healthcare Sector - DirectorsTalk Interviews
Molina Healthcare (MOH) price target increased by 10.23% to 183.44 - MSN
Molina Healthcare, Inc. (MOH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Molina Healthcare, Inc. (MOH) Investigation: Bronstein, Gewirtz - The National Law Review
Leuthold Group LLC Makes New Investment in Molina Healthcare, Inc $MOH - MarketBeat
Molina Healthcare, Inc $MOH Stock Position Decreased by Swiss Life Asset Management Ltd - MarketBeat
Molina Healthcare stock (US6093511094): earnings momentum and Medicaid focus in the US market - AD HOC NEWS
Molina Healthcare Grant For NILP Puts Community Focus In Investor View - Yahoo Finance
Molina Healthcare (MOH) CAO Hebert sells 600 shares at $191.55 - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
Molina Healthcare Grant Links Disability Support With Stock Valuation Questions - Sahm
Have Molina Healthcare Insiders Been Selling Stock? - simplywall.st
Molina Healthcare Inc. stock underperforms Thursday when compared to competitors - MarketWatch
[144] MOLINA HEALTHCARE, INC. SEC Filing - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Encourages Molina Healthcare, Inc. (MOH) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages Molina Healthcare - The National Law Review
AQR Holdings reports 2.86M shares of Molina Healthcare (NYSE: MOH) ownership - Stock Titan
Molina Healthcare Insider Sold Shares Worth $3,314,983, According to a Recent SEC Filing - marketscreener.com
Molina Healthcare (MOH) CLO sells 17,811 shares, retains 67,175 holding - Stock Titan
What Molina Healthcare (MOH)'s 2029 Automation and Premium Targets Mean For Shareholders - Sahm
Molina Healthcare Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Bronstein, Gewirtz & Grossman, LLC Is Investigating Molina Healthcare, Inc. (MOH) And Encourages Shareholders to Connect - ACCESS Newswire
Molina Healthcare and The MolinaCares Accord Donate $120,000 to Support Programming for Young Adults with Disabilities - Business Wire
Are Investors Undervaluing Molina Healthcare (MOH) Right Now? - Yahoo Finance
Q3 EPS Estimate for Molina Healthcare Lowered by Analyst - MarketBeat
Form 144 notice lists restricted/performance shares for MOH (NYSE: MOH) - Stock Titan
Molina Healthcare shareholders approve equity plan amendment and bylaw changes By Investing.com - Investing.com Australia
Molina Healthcare of Michigan and The MolinaCares Accord Donate $130,000 to Libraries for Pilot Programs Addressing Senior Social Isolation - Business Wire
Molina Healthcare stock (US60855R1005): Baird raises price target to $163 - AD HOC NEWS
Truist Raises Price Target on Molina Healthcare to $205 From $180, Keeps Hold Rating - Moomoo
Molina Healthcare Shareholders Approve Governance and Bylaw Changes - TipRanks
Molina Healthcare shareholders approve equity plan amendment and bylaw changes - Investing.com India
Molina Healthcare (NYSE: MOH) OKs larger equity plan and 20% holder special-meeting right - Stock Titan
Molina Healthcare, Inc. Approves Election of Francis S. Soistman as Director - marketscreener.com
Finanzdaten der Molina Healthcare Inc-Aktie (MOH)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):